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Abstract
Background: Various by-products of the cellular metabolism, such as reactive carbonyl species (RCS) are potentially
harmful to cells and tissues, and play a role in many physiological and pathological processes. Among various RCS
is the highly reactive dicarbonyl glyoxal (GO), which is a natural physiological metabolite produced by the auto-
oxidation of glucose, and can form covalent adducts known as advanced glycation endproducts (AGE). We have
previously reported that GO accelerates ageing and causes premature senescence in normal human skin
fibroblasts.
Results: Using a bone marrow-derived telomerase-immortalised mesenchymal stem cell line hMSC-TERT we have
observed that an exposure of cells to 0.75 mM and 1 mM GO induces irreversible cellular senescence within 3
days. Induction of senescence in hMSC-TERT was demonstrated by a variety of markers, including characteristic cell
morphology and enlargement, vacuolisation, multinucleation, induction of senescence associated b-galactosidase,
cell cycle arrest, and increased levels of a cell cycle inhibitor p16. These changes were accompanied by increased
extent of DNA breaks as measured by the comet assay, and increased levels of the AGE product, carboxymethyl-
lysine (CML). Furthermore, the in vitro differentiation potential of hMSC-TERT to become functional osteoblasts was
highly reduced in GO-treated stem cells, as determined by alkaline phosphatase (ALP) activity and mineralized
matrix (MM) formation.
Conclusions: The results of our study imply that an imbalanced glucose metabolism can reduce the functioning
ability of stem cells in vivo both during ageing and during stem cell-based therapeutic interventions.
Introduction
The progressive accumulation of molecular damage is a
universal characteristic of ageing [1-3]. Among the main
causative agents of damage, such as reactive oxygen spe-
cies (ROS), nutritional metabolites and biochemical infide-
lity, the nutritional metabolites are an important source of
molecular damage. For example, an imbalance in the
intracellular glucose metabolism leads to increased levels
of its oxidative breakdown products dicarbonyls glyoxal
(GO), methylglyoxal (MGO), 3-deoxyglucosone (3-DG)
and glucosone. These byproducts of cellular metabolism
belong to the chemical group of a-oxoaldehydes but are
more commonly classed as reactive carbonyl species (RCS)
[4]. Besides being a natural physiological metabolite in the
auto-oxidation of glucose, GO can alternatively be formed
by lipid peroxidation, the degradation of glycated proteins
and DNA oxidation among other reactions [4-9]. GO is
also present in food and beverages, and is an increasingly
used industrial chemical [7,10,11]. The highly reactive car-
bonyl groups of GO can react with lysine, arginine and
cysteine residues of proteins to form covalent adducts
known as advanced glycation end-products (AGE), asso-
ciated with the browning and fluorescence of proteins
[4,5,12]. The accumulation of AGE-damaged proteins by
the carbonyl stress of RCS has been implicated in several
age-related pathologies, such as Alzheimer’s disease, ather-
osclerosis, kidney failure, cataract and diabetes [8,13-15].
The cellular damage induced by GO and other RCS is not
only limited to the proteome but may also harm the gen-
ome and the lipome by various means [7,8,16-18].
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GO or 400 μM MGO leads to accelerated ageing and
the appearance of senescent phenotype within 3 days in
normal human skin fibroblasts [19,20]. Ageing and the
senescent phenotype in skin fibroblasts were demon-
strated by several well established criteria [3], including
morphological phenotype, irreversible growth arrest and
G2 cell cycle arrest, increased senescence-associated b-
galactosidase (SABG) activity, increased H2O2 level,
increased Nε-(carboxymethyl)-lysine (CML) level, and
altered activities of superoxide dismutase and catalase
antioxidant enzymes. We have now utilized this experi-
mental model of induced cellular senescence in vitro for
testing the effects of GO on other cell types, especially
the mesenchymal stem cells (MSC), which are multipo-
tent stem cells capable of differentiating into a variety of
cell types, such as osteoblasts, adipocytes, chondrocytes,
myocytes, neuron-like and endothelial-like cells [21,22].
Here we report the results of our studies on the
effects of GO on growth characteristics, macromolecular
damage, induction of senescence and reduced differen-
tiation ability of telomerase-immortalised human bone
marrow-derived MSC, designated hMSC-TERT [21].
The aim of these studies was to determine how the
imbalanced glucose metabolism observed in vivo during
ageing and age-related diseases, such as diabetes-2, may
have deleterious effects on the survival and differentia-
tion capacity of MSC. Furthermore, this experimental
model of a rapid induction of senescence in immorta-
lized cells provides a reproducible and practical
approach for future studies on basic molecular mechan-
isms of ageing and on testing potential interventions.
Experimental
Chemicals, antibodies and kits
1a,25-Dihydroxyvitamin D3 (Vit-D, calcitrol; Sigma
#D1530), b-glycerophosphate (CALBIOCHEM #35675),
agarose, Low melting point (LMP; Sigma #A9414), Ali-
zarin Red S (Sigma-Aldrich #A5533), alkaline phospha-
tase (Sigma #P-5931), L-ascorbic acid (Sigma #A4544),
p-nitrophenol phosphate (Sigma-Aldrich #N3002), p-
nitrophenol standard solution 10 mM (Sigma #N7660),
propidium iodide (PI; Fluka #81845), RNase A, Bovine
Pancreas (Roche #10109169001), mouse anti-CML
(IgG1; Biologo #CML011), mouse anti-human p16
INK4a
(IgG1; BD-Pharmingen #51-1325GR), polyclonal rabbit
anti-mouse immunoglobins, FITC-conjugated (IgG;
DAKO #F0232), protein assay DC (BIO-RAD #500-0112)
and senescence cells staining kit (Sigma #CS0030).
Cell culture and GO treatment
The cell line used in this study was created by a stable
retroviral transduction of human bone marrow-derived
mesenchymal stem cells with the catalytic subunit of
telomerase with reverse transcriptase activity [21]. The
cell line (designated hMSC-TERT) exhibits all known
characteristics of bone marrow-derived MSC in vitro
and in vivo, and displays an extended lifespan [22].
hMSC-TERT was incubated at 37°C, 5% CO2, 95%
atmospheric air and 95% humidity, and were serially
passaged at a split ratio of 1:4. The complete normal
DMEM culture media contained 2 mM L-glutamine, 4.5
g/L glucose, 10% (v/v) bovine fetal calf serum (FCS),
100 U/mL penicillin and 100 μL/mL streptomycin. At
about 90% confluency the cell cultures were split using
the trypsin/EDTA method. All experiments were per-
formed at population doubling (PD) levels between 52
and 145. Unless otherwise stated, the medium was chan-
ged every three days, cells were seeded with a density of
5200 cells/cm
2 and the cells were always allowed to
grow for 24 h after seeding before any treatments with
GO was given. The duration of GO treatment was 3
days unless otherwise noted. Cell viability was deter-
mined by MTT assay, which showed that doses of up to
1 mM GO were not cytotoxic, but at higher doses, the
cells would shrink and die in less than 24 h (data not
shown).
Cellular growth analysis
Cells used for the 10-day survival analysis were seeded
in several 12-well plates with 8,000 cells per well (~2100
cells/cm
2) in normal medium. After 24 h, the culture
medium was replaced with either fresh normal medium
or the medium containing 0.75 mM GO or 1 mM GO.
The treatment was continued either for 10 days or for 3
days followed by the replacement of the GO-containing
medium with the normal medium for the remaining 7
days. Three replicates of wells for each condition were
trypsinized and counted after 1, 3, 5, 7 and 10 days of
treatment. Cell counting was performed in triplicates,
using a Bürker-Türk hemocytometer.
Cellular morphology analysis
The cells were seeded in a 6-well plate with 50,000 cells
per well (~5200 cells/cm
2). After 24 h the cells were
treated with various doses of GO for 3 days and then
observed for morphological appearance, using a phase-
contrast microscope. The cell size distribution was
determined by FACS analysis. The senescence-associated
b-galactosidase (SABG) assay was performed using the
histochemical staining kit from Sigma-Aldrich [23].
Cell cycle analysis by PI staining and flow cytometry
The cells were seeded in a 6-well plate, and after 24 h
treated with various doses of GO for 3 days. The cells
were trypsinized, resuspended in 1 mL normal medium
before centrifugation at 300 × g for 5 min, and the
supernatant was carefully removed in order not to
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cold ethanol for 1 h at 4°C, were centrifuged again and
were resuspended in 1 mL PBS. In order to degrade any
double stranded RNA before the PI staining, 100 μL
RNase A (100 μg/mL) was added and the cells incubated
for 15 min at 37°C without CO2. Thereafter, 400 μLP I
(50 μg/mL) was added and the cells were incubated for
1 h at room temperature (RT) in dark. During the flow
cytometry analysis the cells were sorted from debris by
FSC and SSC gating and any doublets were sorted out
by pulse processing by using the PI-height and PI-area.
The data were collected in linear scale and the percen-
tage of cells in different cell cycle phases was defined by
Watson pragmatic model fit by Flow Jo (Tree star Inc.)
p16 and CML detection by immunofluorescence and flow
cytometry
The cells were seeded in 6-well plates, and after 24 h
the cells were treated with various doses of GO for 3
days. The cells were trypsinized and resuspended in 1
mL wash buffer (PBS with 5% FCS) before centrifuga-
tion at 600 g for 5 min, fixed first in 150 μL0 . 2 5 %P F A
for 20 min at 4°C then washed twice and fixed again
with 150 μL 70% cold methanol for 1 h at 4°C, washed
and then permeabilised with 150 μL 0.25% Triton x-100
for 5 min on ice, washed again before incubating for 30
min at RT with primary antibody. For p16 detection 100
μL of 1:10000 mouse anti-human p16
INK4a was used in
10% FCS-PBS to a final concentration of 25 ng/mL. For
CML detection, the mouse anti-CML was diluted
1:10000 in 10% FCS-PBS to a final concentration of 25
ng/mL. The cells were washed twice before adding 100
μL solution of the FITC-conjugated secondary anti-
mouse antibody and incubated 30 min at RT in dark.
The secondary antibody was diluted 1:40 in 10% FCS-
PBS, according to manufacturer’s recommendations,
resulting in the final concentration of 75 μg/mL. The
cells were washed and resuspended in 1 mL wash-buffer
and were analysed immediately by flow cytometry, as
described above. The data are presented as geometric
mean values of fluorescence intensity, as collected on a
logarithmic scale, and the CV (coefficient of variation
(CV) representing the peak width are included.
Comet assay
This variant of the assay was as modified by Singh et al.
1988 [24]. The cells were seeded in a 6-well plate, and
after 24 h the cells were treated with various doses of
GO for 24 h or 3 days. The positive controls were pre-
pared by adding 0.2 mM H2O2 for 20 min. After treat-
ment, the cells were trypsinized and counted, and
50,000 cells from each sample were resuspended in 1
mL PBS and centrifuged for 1 min at 1000 g. The super-
natant was removed and the cells were resuspended in
100 μL low melting point (LMP) agarose, which had
been melted and maintained at 37°C in water-bath
before use. 75 μL of this LMP agarose cell-suspension
was added on top of previously prepared normal melting
point (NMP) agarose slides. The thin NMP agarose-
coating reduces the chance of the LMP agarose layer to
fall off during the procedure. The cell-suspension was
added very quickly before the LMP agarose hardened. A
coverslip was added on top and the slides were placed
at 4°C for 10 min for agarose to harden. The coverslips
were gently removed and the slides submerged in lysis
solution (2.5 M NaCl, 100 mM Na2EDTA, 10 mM Tris
base, pH 10) at 4°C for 2 h and kept in dark. The slides
were gently rinsed in water and placed in electrophor-
esis buffer (300 mM NaOH, 1 mM Na2EDTA, pH > 13)
at 4°C for 40 min to allow unwinding. The electrophor-
esis was done at 15 V (0.8 V/cm) and 300 mA at 4°C
for 20 min. The slides were gently washed three times
in neutralization buffer (0.4 M Tris base, pH 7.5) for 5
min and then dehydrated twice in 100% ethanol for 5
min at RT. 20 μL ethidium bromide (10 mg/mL) was
added to each sample and coverslips applied. The extent
of DNA damage was evaluated under UV light by using
a fluorescence microscope, and several pictures were
taken to represent at least 50 cells per sample from dif-
ferent areas on the slide. Cells near the slide-edges were
avoided due to electrophoresis-distortion in these areas.
The pictures were analyzed by image analysis software
(AutoComet Cometscore Freeware version 1.5 of Tritek
Corporation). The cutoff value was adjusted to avoid
saturation but kept constant in all samples. The full
length and the head-centre of each comet were desig-
nated by a drag-box and the percentage of DNA in each
comet tail quantified by the software.
Alkaline phosphatase activity assay
An established marker for osteoblastic differentiation is
the expression and activity of alkaline phosphatase
(ALP) after treatment with Vit-D or calcitrol [22]. The
cells were seeded in T25 flasks with 52,000 cells per
flask (~2100 cells/cm
2). After 24 h the cells were treated
with various doses of GO for 3 days. The cells were
trypsinized, counted and reseeded in 12-well plates with
precisely 8,000 cells per well (~2100 cells/cm
2). Preli-
minary experiments showed that this reseeding step for
cells was necessary to avoid crowding in order for opti-
mum ALP detection. After 24 h the normal medium
was replaced with medium containing Vit-D (10
-8 M).
The cells were cultured for 7 days after which two of
the three replicates were used for the ALP assay and
one was used for protein quantification.
The ALP activity was measured by washing the cells
twice with PBS, adding 250 μL alkaline buffer solution
per well, and incubating the cells for 10 min at 37°C to
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mM pNPP diluted in alkaline buffer solution) was added
and the plates incubated for 30 min at 37°C. The com-
mercial ALP used for a standard curve had been sub-
d i l u t e di nt h er a n g ef r o m5×1 0
-5 U/μLt o6 . 2 5×1 0
-8
U/μL in 200 μL of the same substrate solution and incu-
bated in a 96-well plate, simultaneously with the sam-
ples. Two aliquots of 200 μL from each well were
transferred to the 96-well plate and the plate was read
in a microplate reader at A415 nm with A595 nm as a
reference. To level out the difference in density from
the GO induced growth arrest, the average ALP activity
from each replicate was related to the corresponding
cellular protein concentration in the samples.
Mineralised matrix assay
Mineralised matrix (MM) is formed during osteoblastic
differentiation when the osteoblasts mineralise. In this
modified assay, MM formation was induced by incubating
the cells for 10 days with complete DMEM containing 50
μg/mL L-ascorbic acid, 10 mM b-glycerophosphate, and
10
-8 M Vit-D (MM culture conditions) [22]. The presence
of calcium was detected by staining with the dye Alizarin
Red S which binds selectively to calcium salts. The cells
were seeded in 12-well plates with 8,000 cells per well
(~2100 cells/cm
2). After 24 h the cells were treated with
various doses of GO for 3 days then the medium was
changed for the MM culturing medium. The Alizarin red
S staining was performed by washing the cells three times
with PBS, fixing with 70% ethanol for 1 h at -18°C, wash-
ing with dH2O and staining with 0.5 mL 40 mM Alizarin
Red S, pH 4.2 (dissolved in dH2O) for 1 h at RT on a sha-
ker. The cells were washed thoroughly five times with
dH2O to remove unspecific staining and incubated in 10%
(wt/vol) cetylpyridinium chloride (CPC) (dissolved in
dH2O) for 1 h to elute the stain. The absorbance of the
eluted stain was measured in 200 μL aliquots in a micro-
plate reader at A595 nm and related with an Alizarin Red S
standard curve of 0-10 mM sub-dilutions in 10% CPC. All
samples were within the linear interval of the standard
curve. The values from each condition was normalised
with the corresponding cellular protein concentration
from the sample, and the data were presented as mM Ali-
zarin Red S/μg total protein.
For protein quantification the cells were lysed by a
CHAPS-based lysis buffer and the protein was estimated
by the DC Protein Assay kit from BIO-RAD according
to manufacturer’s protocol. All samples were related
with a standard curve of BSA subdilutions in the range
of 0-2 mg/mL.
Statistical analysis
All statistical analysis in this study were performed by
Student’sp a i r e dt-test, as the compared cell populations
a r ec o n s i d e r e dt ob em a t c h e ds i n c et h e yh a v et h es a m e
origin. Figures marked with single or double asterisks
indicate significant different groups from the control
indicated in the figure legend, * = p < 0.01, ** = p < 0.05.
Results
Induction of cellular senescence in hMSC-TERT
Exposure of telomerase immortalized hMSC-TERT cells
to GO resulted in the induction of senescence within 3
days, as judged by several criteria. The selection of GO
doses (0.75 mM and 1 mM) was made on the basis of a
MTT assay performed on hMSC-TERT and on our pre-
viously published results on human skin fibroblasts
[19,20]. Figure 1 shows that GO-treated cells attained
typical in vitro senescent cell morphology in terms of
becoming significantly large, irregular, flattened, vacuo-
lated, multinucleated and heterogeneous. Although
these morphological changes could also be seen in cells
treated with 0.75 mM GO, the effects were more dra-
matic after treatment with 1 mM GO (Figure 1, upper
panel). Furthermore, this GO-induced senescent pheno-
type was maintained even after the removal of GO dur-
ing the follow up period of 3 days (Figure 1, lower
panel). The increased heterogeneity of the cellular size
was obvious in cell suspension (Figure 2, upper panel),
and was further confirmed and quantified by flow cyto-
metry (Figure 2, lower panel). There was a clear increase
in the proportion of large cells within a cell population
with increasing doses of GO, as measured by the shift in
the mean value of the forward scatter. Average cell size
was also quantified using an automated cell counter
(Countess
®, Invitrogen). After 3 days of GO treatment
the average cell sizes were 21.8 μm, 23.7 μm and 28.7
μm for the control, 0.75 mM and 1 mM GO-treated
cells, respectively (data not shown).
Another cellular biomarker of senescent cells is the
increase in the senescence associated b-galactosidase
(SABG) activity [23]. The number of SABG-positive
cells was counted among at least 500 cells in each sam-
ple in two independent experiments. Figure 3 shows
that there was a several fold increase in the number of
SABG-positive cells after GO-treatment for 3 days (4.5-
and 9.2-fold increase for 0.75 mM and 1 mM GO,
respectively).
The effect of GO on growth rate was determined by a
10-day cell growth assay where the cells were treated
either continuously or only during the first 3 days with
0.75 mM and 1 mM GO. Figure 4 shows that whereas
the number of cells in untreated control cultures
increased about a hundred-fold during the 10-day per-
iod, a continuous treatment with GO resulted in an
almost total inhibition of cell growth and proliferation
during this period. However, if the GO treatment was
limited to 3 days followed by replacement with normal
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Page 4 of 13Figure 1 Cellular morphology of hMSC-TERT after GO treatment. The upper panel shows cell enlargement, vacuolation and an increased
heterogeneity after 3 days of treatment with 0.75 mM and 1 mM GO. The lower panel shows that after 3 days of GO treatment, followed by 3
days in normal medium without GO, the treated cells did not revert back to the normal morphology and maintained a senescent appearance.
Pictures were taken using a 10× objective lens on a phase-contrast microscope.
Figure 2 Increase in hMSC-TERT cell size and heterogeneity with GO treatment in suspension (upper panel, 10× objective lens), and
confirmed by FACS analysis (lower panel). The increase in the average value of the forward scatter with GO treatment indicates an increase
in average size. The coefficient variation (CV) was 16%, 17% and 24%, respectively.
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in 0.75 mM treated cultures, but almost no increase in 1
mM-treated cultures, during the following 7 days. It is
not clear if the recovery in growth of 0.75 mM-treated
cultures after 7 days is due to a sub-set of resistant cells
or whether all cells were able to recover from GO-
induced cell growth inhibition after removal of GO.
Another parameter and biomarker of cellular senes-
cence in vitro is the cell cycle arrest dynamics including
an increased level of cell cycle inhibitor p16 [25]. We
have analysed the cell cycle distribution and the levels
of p16 of GO-treated and untreated hMSC-TERT by
immunofluorescence and FACS analysis. This experi-
ment does not distinguish between the normal dividing
cells in the G1 phase of the cell cycle and those which
have entered irreversible G0. The distribution of phases
by the Watson Pragmatic model was determined by
flow cytometry analysis software after PI staining. The
cells were gated by their FSC and SSC to represent the
main population and to avoid debris. Hereafter they
were pulse processed to avoid cell aggregates by gating
according to the area (FL2-A) and width (FL2-W) of the
pulse signal from the fluorescence detector (not shown).
To distinguish between the 2 n and 4 n DNA content in
the cells, the characteristics of PI fluorescence (FL2-H)
were related with cell number and the percentage of
cells in each phase was calculated according to the Wat-
son pragmatic fit model by Flow-Jo software [26].
Figure 5 shows that 1 mM GO treatment caused the
growth arrest in hMSC-TERT cells as the frequency of
cells in G2/M-phase increased from 1.33% to 13.26%. A
slight increase in the frequency of cells in the S-phase
was not caused by an increased number of cells entering
into this phase (as also observed with the reduced
growth rates), but rather it indicates that the S-phase
progression is severely delayed [27]. The observed
growth arrest in GO-treated cells was further supported
by the observation that the levels of the cell cycle check
point marker p16 increased by 61% in hMSC-TERT
cells treated with 0.75 mM and 1 mM (Figure 6).
Induction of macromolecular damage in hMSC-TERT by
GO
The extent of DNA damage induced by GO was deter-
mined by the comet assay, which measures the prevalence
of single- and double-strand breaks. The level of DNA
damage was estimated from the percentage of DNA in the
Figure 3 Percentage of senescence associated b-galactosidase
(SABG) positive hMSC-TERT after 3 days of GO treatment. Data
from two independent experiments are presented as Ex1 and Ex2,
respectively.
Figure 4 Effect of GO on growth and proliferation of hMSC-
TERT during a period of 10 days. Cells were either treated with
GO for 3 days followed by 7 days in normal medium or were
treated with GO continuously for 10 days. The growth curve for the
untreated control is shown broken in order to represent the large
change in the scale for cell numbers on Y-axis.
Figure 5 Frequency (%) of cells in different phases of the cell
cycle in untreated control and in GO-treated hMSC-TERT cells (3
days, 1 mM). The frequency is calculated by the Watson pragmatic
fit model by the Flow-Jo software according to the 2 n and 4 n peaks
from a histogram relating the PI fluorescence with cell number.
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phoresis as broken DNA moves faster in the current
(Figure 7). The percentage of DNA in the tails versus the
core was analyzed by Tritek Cometscore Freeware version
1.5., and the results show that hMSC-TERT cells treated
with GO for 3 days had significantly higher levels of
damaged DNA than the untreated cells (Figure 8). As the
positive control, DNA damage was induced in the cells by
treatment with 0.2 mM H2O2 for 20 min. All samples
were significantly different from the untreated controls as
calculated by Student’sp a i r e dt-test.
Nε-Carboxymethyl-Lysine (CML) adducts are the most
prevalent form of AGEs, and previous studies have shown
that CML adduct formation is induced by GO [28]. The
levels of CML adducts was determined in two independent
experiments, using immunofluorescence and flow cytome-
try. Figure 9 (upper panel) shows the fluorescence intensity
distribution from one experiment, and the histogram (lower
panel) shows the geometric mean values of the fluorescence
intensity in GO-treated and control cells from the same
experiment. There was about a 2-fold increase in CML
adducts in GO-treated hMSC-TERT in both experiments.
Figure 6 Changes in the levels of p16 in hMSC-TERT after 3 days of GO treatment. The upper panel shows FACS-distribution of
fluorescence intensity, whose geometric mean values are presented in the histogram in the lower panel. The coefficient variation (CV) was 71%,
54% and 55%, respectively.
Figure 7 Induction of single- and double-stranded DNA damage in hMSC-TERT treated with GO for 24 h, as determined by the comet
assay. The positive control was with 0.2 mM H2O2 (HP) treatment for 20 min. Pictures were taken with a 10× objective lens.
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To determine the effects of GO on the osteoblastic differ-
ential potential, two markers of differentiation, ALP and
MM, were analysed in hMSC-TERT cells after exposure
to appropriate conditions for the induction of differentia-
tion. The quantified activity of ALP was related to a pNP
standard curve and then related to the cellular protein
content of the sample in order to take the reduced growth
of the GO samples into consideration. The results were
normalised against the value of the undifferentiated con-
trol for comparison. The assay was performed five times
representing a broad range of population doubling levels
(PDL 72, 93, 95 104 and 135), each performed with two
replicates. All experiments showed the same tendency of
significantly reduced differentiation in the GO-treated
samples, despite an apparently large variation. Figure 10
shows that a pretreatment of hMSC-TERT cells with GO
for 3 days reduced the extent of osteoblastic differentia-
tion, on an average, by 61% in 0.75 mM GO-treated cells
and by 97% in 1 mM GO-treated cells, as compared with
the extent of differentiation in untreated controls.
The extent of formation of MM as a marker of osteo-
blastic differentiation was determined by Alizarin Red S-
calcium complex formation, which was quantified by
absorbance after eluting the stain with cetylpyridinium
chloride (CPC). The quantified Alizarin red S staining in
each sample was related to a standard curve, and then
to the total cellular protein content of the sample.
Figure 11 shows the microscopic pictures of hMSC-
TERT induced to produce MM under various condi-
tions. A pretreatment of cells to GO almost completely
inhibited the formation of MM (Figure 12).
Figure 8 Extent of DNA damage measured as the percentage
of tail DNA in the comet assay in hMSC-TERT cells treated with
GO for 3 days. Cells exposed to 0.2 mM H2O2 (HP) for 20 min, or
to 0.75 mM and 1 mM GO for 3 days were significantly different
from the untreated controls, as calculated by paired t-test (n = 96, *
= p < 0.01). The error bars indicate standard deviation.
Figure 9 FACS-based measurement of the levels of CML adducts in hMSC-TERT cells after 3 days of GO treatment. The geometric mean
values are presented in the histogram in the lower panel. The coefficient variation (CV) was 53%, 42% and 45%, respectively.
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In the present study, we have extended the previous
observations made on the normal human skin fibro-
blasts [19] to immortalized MSC showing that the glu-
cose metabolite GO causes molecular damage to DNA
and proteins, and leads to the rapid emergence of a
senescent phenotype in cells in vitro. Using a bone mar-
row-derived telomerase-immortalised mesenchymal
stem cell line hMSC-TERT we have now shown that an
exposure of cells to 0.75 mM and 1 mM GO induces
irreversible cellular senescence within 3 days. Induction
of cellular senescence in hMSC-TERT was demonstrated
by a variety of well established markers, such as charac-
teristic senescent morphology and enlargement,
increased vacuolisation, multinucleation, SABG activity,
cell cycle arrest, and increased levels of a cell cycle inhi-
bitor p16 [3]. The increase in the extent of single- and
double-strand DNA breaks as measured by the comet
assay, and increased levels of the AGE product CML in
cells appear to contribute as causative agents to the
GO-induced senescence among other potential mechan-
isms. Other studies performed on keratinocytes support
our observations that GO treatment increases the level
of DNA breaks [17]. Our observations of increased
DNA damage and CML formation are in line with the
well-established fact that increased levels of macromole-
cular damage, whether spontaneously accumulated dur-
ing serial passaging or induced by high levels of stress,
results in the upregulation of several cell cycle check
point regulators [25,29,30]. Especially the elevated levels
of p16 and p21 are characteristic markers of cellular
senescence in vitro and in vivo. Additionally, p16 in par-
ticular may play a role in the initiation of the senescence
programme [31,32].
Functional assays with respect to the differentiation
potential of hMSC-TERT cells to osteoblastic phenotype
in vitro showed that GO-treated stem cells had highly
reduced ability to become functional osteoblasts, as
determined by ALP activity and MM formation. It is
well known that during ageing bone remodeling is sig-
nificantly imbalanced, and often leads to the onset of
osteoporosis [33]. The reasons considered for reduced
bone formation during ageing include a reduced MSC
niche, an increase in bone-marrow adiposity, osteoblas-
tic apoptosis, and increased number of active osteoclasts
[34]. As regard to the role of hMSC, studies indicate
that it is primarily the decreased proliferative capacity of
hMSC and the changes in the bone micro-environment
which are responsible for the age-related changes in
osteoblast function [35,36]. Additionally, age-related
pathologies, such as imbalanced glucose metabolism
leading to diabetes-2, further enhance the problems of
altered bone remodeling. The results of our present
study imply that an imbalanced glucose metabolism can
reduce the functioning ability of stem cells in vivo both
during ageing and during stem cell-based regenerative
therapy.
Our study was performed with a telomerase-immorta-
lized stem cell-line which possesses an unlimited repli-
cative potential due to its constitutively active
telomerase [21]. However, it is well known that one of
the reasons for the replicative senescence of normal
cells is a progressive loss of telomeres during repeated
cell proliferation, associated with a lack of telomerase
activity [37,38]. For example, in the case of normal cul-
tured hMSC from a 33 yr old donor, an average of 88
telomeric base pairs was lost per PD during serial
expansion, leading to increased genomic instability and
final growth arrest after 26 PD [39]. Furthermore, telo-
meres also have increased sensitivity to oxidative
damage due to lack of adequate repair mechanisms in
the telomere region [40]. Studies performed on other
cell types have shown increased rates of telomere short-
ening caused by single-strand breaks when cells were
treated with oxidative stressors such as H2O2 [41] or
hyperoxia [42].
Since we had observed that GO increased the levels of
D N Ad a m a g ei nh M S C - T E R T ,w em a d es o m ep r e l i m i n -
ary investigations on the potential damaging effect of GO
on telomere length and telomerase activity, by using a
TRF assay and a RQ-TRAP assay [43], respectively.
Although there was some decrease in telomerase activity,
there was no detectable difference in telomere length
after three days of GO treatment (data not shown).T h i s
Figure 10 Effect of GO on ALP activity (relative arbitrary units)
as a marker of osteoblastic differentiation of hMSC-TERT cells.
ALP levels in 0.75 mM and 1 mM GO-treated cells were significantly
different from the differentiated control as calculated by paired t-
test (n = 10, * = p < 0.01). The error bars indicate standard
deviation. (D: differentiated; U: undifferentiated)
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Page 9 of 13Figure 11 Effect of GO on mineralized matrix (MM) formation as a marker of osteoblastic differentiation, as detected by staining with
Alizarin red S. The upper panel of 8 wells is a whole-plate photograph with two replicates of each condition. The lower panel shows pictures
of MM formation in undifferentiated and differentiated control cells, and in cells pretreated with GO for 3 days (10× objective lens)
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Page 10 of 13inconsistency between reduced telomerase activity and
unaltered telomere length can be explained by the fact
that telomerase is constitutively and ectopically expressed
in the hMSC-TERT cell line, and thus the residual activ-
ity may be sufficient to uphold the telomere length.
Another reason for this can be the reduced proliferation
of GO-treated cells. With fewer cycles of DNA replica-
t i o nl e s so ft h et e l o m e r el e n g t hw i l lb el o s t ,d e s p i t ea
reduced activity of telomerase. The fact that the telo-
meres did not show shortening after GO treatment indi-
cates that it did not cause significant damage to the
telomeres, and so the observed GO-induced senescence
can be characterized as being telomere-independent.
Based on our observations that GO can induce senes-
cence in normal and immortalized cells, it is interesting
to consider the human exposure to reactive carbonyl
species (RCS) in general. The primary sources of expo-
sure to RCS are the endogenous production or dietary
uptake. The main concern of RCS is its ability to glycate
both cellular and extracellular proteins, resulting in the
formation of advanced glycation end-products (AGEs).
Both AGE and RCS are considered to play a crucial role
in several age-related pathological conditions including
diabetes, Alzheimer’s disease and cardiovascular diseases
[13-15]. With respect to diabetes, the hyperglycemic
state causes increased auto-oxidation of glucose to form
elevated levels of RCS glyoxal and methylglyoxal in the
blood plasma of diabetes patients [44,45], which may
contribute to the long-term complications of this dis-
ease, including cataracts and atherosclerosis. The RCSs
are highly capable of modifying lysine, cysteine and
especially arginine residues as they do so with high reac-
tion rates [46]. Because arginine is present in high abun-
dance in the functional sites of many proteins, GO may
disrupt their functionality by reducing enzymatic activ-
ity, receptor-ligand or protein-nucleotide binding. It
may, however, be the extracellular proteins which are
most susceptible to glycoxidative stress, due to their low
turnover rate. Furthermore, studies performed on dia-
b e t i cr a t sh a v es h o w na5 - f o l di n c r e a s ei nG O - d e r i v e d
modification of a specific arginine in the extracellular
protein collagen IV [4]. This arginine is important for
t h ea s s e m b l ya n ds t a b i l i t yo f the collagen IV network,
which influences the thickness of the basement mem-
brane in capillaries and small vessels. Other studies have
shown that AGE-forming inhibitors reduce the forma-
tion of atherosclerotic plaques in the aortas of diabetic
mice [47]. The RCS-induced formation of AGEs could
thus be influencing the vascular complications observed
in diabetes patients.
Besides the endogenous metabolic exposure to GO due
to glucose auto-oxidation, the dietary exposure of RCS
may be hazardous to human health. RCSs may be formed
in large quantities during the thermal processing of foods,
such as roasting, frying and baking. The levels of both GO
and MGO have been found to increase with increased
baking time and heat exposure in cookies [10]. Another
source of high dicarbonyl exposure is the carbonated soft
drinks containing high fructose corn syrup [11]. It is
important to investigate if the exposure to these RCS con-
taminants in our diet could influence our susceptibility to
age-related human diseases by inducing premature senes-
cence in both differentiated cells and stem cells.
Finally, the results of our current study demonstrate
that the glucose metabolite GO can induce cellular
senescence in stem cells similar to the stress-induced
premature senescence (SIPS) model [48]. Our in vitro
model of GO-induced senescence in telomerase-immor-
talized human mesenchymal stem cells may be similarly
utilized in ageing interventional studies. The combina-
tion of an immortal cell line with the ability to rapidly
induce ageing at any chosen time-point, can open up
several practical possibilities for testing potential ageing
modulatory natural and synthetic compounds.
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